TrialJournal of pharmacokinetics and pharmacodynamics2016

Analysis of peginterferon β-1a exposure and Gd-enhanced lesion or T2 lesion response in relapsing-remitting multiple sclerosis patients.

Yaming Hang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.